February 6, 2024

Risk of potential hepatotoxicity from pirfenidone or nintedanib in patients with idiopathic pulmonary fibrosis: results of a retrospective analysis of a large insurance database in Taiwan – Frontiers

February 6, 2024

The epithelium in idiopathic pulmonary fibrosis: breaking the barrier – Frontiers

February 5, 2024

Progress in understanding and treating idiopathic pulmonary fibrosis: recent insights and emerging therapies – Frontiers

February 5, 2024

Changes in serum metabolomics in idiopathic pulmonary fibrosis and effect of approved antifibrotic medication – Frontiers

February 5, 2024

The Effect of Cardiovascular Medications on Disease-Related Outcomes in Idiopathic Pulmonary Fibrosis: A Systematic Review and Meta-Analysis – Frontiers